Inactive Instrument
Stemcell Holdings, Inc. Share Price Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 24/05/2021 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 16.43L | |
| +2.11% | -1.55% | +17.99% | -8.38% | 6.63TCr | |
| +1.23% | +2.80% | +37.51% | +202.14% | 5.26TCr | |
| +10.08% | +51.80% | +51.80% | +51.80% | 4.33TCr | |
| -1.32% | -6.34% | -56.98% | -57.24% | 3.86TCr | |
| +1.22% | -1.54% | +52.96% | -26.78% | 2.96TCr | |
| +1.04% | +0.43% | +67.05% | +85.56% | 2.33TCr | |
| -4.67% | -11.68% | +60.54% | -55.61% | 2.26TCr | |
| -1.21% | -4.51% | +2.22% | +174.24% | 2.02TCr | |
| -0.22% | -0.95% | +61.97% | +123.78% | 1.63TCr | |
| Average | +0.84% | -1.33% | +32.78% | +54.39% | 3.48TCr | |
| Weighted average by Cap. | +1.66% | -0.65% | +28.00% | +49.82% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 33.39L 29.32L 27.27L 25.02L 47.02L 32Cr 47.74L 3.24Cr 1.27Cr 16Cr 1.25Cr 1.23Cr 55Cr | 61.8L 54.28L 50.48L 46.32L 87.03L 60Cr 88.37L 5.99Cr 2.34Cr 29Cr 2.32Cr 2.27Cr 101.16Cr |
| Net income | 14.02L 12.32L 11.45L 10.51L 19.75L 14Cr 20.05L 1.36Cr 53.14L 6.64Cr 52.65L 51.51L 23Cr | 24.1L 21.16L 19.68L 18.06L 33.94L 23Cr 34.46L 2.34Cr 91.31L 11Cr 90.46L 88.51L 39Cr |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
